Apidra Injection, Solution
Pricing Report NDC 0088-2500-33

Current NADAC: $8.16058 per ML · Effective Aug 19, 2026

Current Package Pricing Information

The current wholesale acquisition cost for Apidra (NDC 0088-2500-33) is $8.16058 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human prescription drug provided by Sanofi-aventis U.s. Llc, this medication is distributed in a 1 VIAL, GLASS in 1 CARTON / 10 mL in 1 VIAL, GLASS configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$8.16058
Per ML

Effective Date
Aug 19, 2026
Data Status
As of Sep 09, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 VIAL, GLASS in 1 CARTON / 10 mL in 1 VIAL, GLASS
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Sep 2013, the NADAC wholesale price for (NDC ) has moved within a range of $8.16058 to $27.27950 per ML. Over this 12 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$8.1606 - $27.2795
Market Volatility
234.28% Variance
Latest Trend
No Change

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $8.16058 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jul 22, 2026 $8.16072 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jun 17, 2026 $8.16171 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
May 20, 2026 $8.17670 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Apr 22, 2026 $8.17173 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Mar 18, 2026 $8.17481 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Feb 18, 2026 $8.16889 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jan 21, 2026 $8.17168 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Dec 17, 2025 $8.17001 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Nov 19, 2025 $8.16312 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Oct 22, 2025 $8.17150 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Sep 17, 2025 $8.17337 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026